Related Experiment Video

Updated: Feb 13, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.9K

Bioinspired and stimuli-responsive nanocomposites for targeted therapy in ovarian and endometrial tumors

Jihang Yao1, Lulu Liu2, Xiufei Teng2

  • 1Department Gynecology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

International Journal of Pharmaceutics: X
|February 12, 2026
PubMed

Insights

Advanced nanocomposites offer new targeted therapies for ovarian and endometrial cancers. These bioinspired materials improve drug delivery and reduce toxicity, showing great potential in gynecologic oncology.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Gynecologic Oncology

Background:

  • Ovarian and endometrial cancers present significant therapeutic challenges, often diagnosed late and resistant to conventional treatments.
  • Developing novel therapeutic strategies is crucial for improving patient outcomes in gynecologic oncology.

Purpose of the Study:

  • To review the design principles and therapeutic potential of multiscale, bioinspired, and stimuli-responsive nanocomposites for ovarian and endometrial cancers.
  • To explore how these nanocomposites can enhance targeted drug delivery and overcome treatment resistance.

Main Methods:

  • Examination of hierarchical structures in nanocomposites ranging from micrometers to nanometers.
  • Analysis of stimuli-responsive elements (pH, temperature, magnetic fields) for controlled drug release.
  • Review of bioinspired designs mimicking the tumor microenvironment for enhanced specificity.

Main Results:

  • Nanocomposites demonstrate enhanced drug delivery efficiency and reduced systemic toxicity.
  • Stimuli-responsive features enable precise targeting and controlled therapeutic agent release.
  • These materials show potential for replicating tumor microenvironments and improving targeting specificity.

Conclusions:

  • Multiscale, bioinspired, and stimuli-responsive nanocomposites represent a promising frontier in gynecologic oncology.
  • These advanced materials offer potential for personalized treatments with improved efficacy and safety profiles.
  • Further research and clinical translation are warranted to fully realize their potential in treating ovarian and endometrial cancers.
Keywords:
Endometrial tumorsOvarian cancerStimuli-responsive nanocompositesTargeted drug deliveryTumor microenvironment

More Related Videos

Irrelevant Stimuli and Action Control: Analyzing the Influence of Ignored Stimuli via the Distractor-Response Binding Paradigm12:12

Irrelevant Stimuli and Action Control: Analyzing the Influence of Ignored Stimuli via the Distractor-Response Binding Paradigm

Published on: May 14, 2014

11.0K
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Published on: November 7, 2015

11.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.2K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
460
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
84.1K